Kyle Lefkoff News Today

A company providing a single platform to support clients’ clinical trial journeys has closed a $3 million Series A funding.

The ongoing pandemic has created a wealth of interest from venture capital investors and the broader public in what biotech companies are able to achieve if it’s flush with resources. That was the sentiment of a group of Boulder area biotechnology industry leaders, who met virtually at BizWest’s CEO Roundtable on the biotechnology industry Tuesday morning. Steady stream of investor dollars Biotech was one of the few industries that was relatively unaffected from a financial standpoint durin...